Viewing nowCombinationTelotwin Tablet 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Youngil Pharmaceutical Co., Ltd.

MFDS item code 201901587 · Approved 2019.03.15 · Insurance code 649405160
Treatment of essential hypertension not controlled with monotherapy
This medication helps lower blood pressure in patients with essential hypertension where blood pressure is not sufficiently controlled with either amlodipine or telmisartan monotherapy. It can effectively lower blood pressure and help prevent complications. Therefore, this drug is used for the treatment of essential hypertension.
The recommended dose of this drug is 1 tablet once daily, taken with water, regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning), if possible. Before administering this drug, it is recommended to adjust the dose of the individual components (telmisartan or amlodipine); however, if blood pressure is not controlled with an individual component as described below, switching directly to this drug may be considered. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. - 80/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or this drug 40/10 milligrams. For patients taking telmisartan and amlodipine concomitantly, they may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience (limited to this drug 40/5 milligrams and 80/10 milligrams). ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to begin treatment at a low dose and increase it gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients 75 years of age and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
○ Children: Use of this drug is not recommended in pediatric patients 18 years of age or younger, as its safety and efficacy have not been established.
This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so it should not be used during pregnancy. If pregnancy is confirmed, the use of this medication should be discontinued immediately and other treatment options should be sought. This medication should not be administered to patients with certain conditions. For example, it should not be taken by individuals allergic to any of its components, pregnant women, nursing mothers, patients with severely impaired liver function, and patients with specific cardiovascular diseases. Additionally, this medication should be used with caution in patients with primary aldosteronism, certain heart valve diseases, liver dysfunction, gastrointestinal diseases, renal dysfunction, and the elderly. Patients taking this medication may experience side effects such as dizziness and peripheral edema, and in severe cases, symptoms like fainting may also occur. Use of this medication during pregnancy poses risks such as diminished renal function in the fetus, reduced amniotic fluid, and cranial formation abnormalities, so it must be avoided. Nursing mothers are also advised against taking this medication. This medication is not recommended for pediatric patients under 18 years of age as safety and efficacy have not been sufficiently established. Elderly patients may be more sensitive to this medication, so caution is needed during administration, and dosage adjustments may be required. In cases of overdose, symptoms like hypotension, dizziness, and cardiac dysfunction may occur, and immediate medical attention should be sought for appropriate treatment. This medication may interact with other drugs, so it is essential to inform healthcare providers of any other medications being taken. As this medication regulates blood pressure, if symptoms of hypotension appear, the patient should lie down and rest and receive treatment at a hospital if necessary. During the administration of this medication, caution is advised when driving or operating hazardous machinery as drowsiness or dizziness may occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that blocks light and at a temperature between 1 degree and 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness and prevents deterioration.
White or off-white rectangular tablet
30 tablets/box [(10 tablets/Alu-Alu x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Youngil Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.